Search results for: 'research area tyrosine kinase insulin receptor'
- A8557 TAE226 (NVP-TAE226)1 CitationTarget: FAKSummary: FAK inhibitor,potent and ATP-competitive
- BA6412 NT219Summary: NT219 is a potent inhibitor of insulin receptor substrate 1/2.
- BA2785 BMS-536924Summary: BMS-536924 is an orally active, competitive and selective inhibitor of insulin-like growth factor receptor kinase and insulin receptor at 100nM and 73nM, respectively.
- A3125 5-IodotubercidinTarget: Adenosine KinasesSummary: Adenosine kinase inhibitor,potent
- A3194 AST 4871 CitationTarget: RETSummary: RET kinase inhibitor
- BA2759 BafetinibSummary: Bafetinib is an orally active tyrosine kinase inhibitor.
- BA8396 Tyrosinase-IN-16Summary: Tyrosinase-IN-16 is a tyrosine kinase (Tyrosinase) inhibitor with Ki=470nM.
- BA8810 HG-7-86-01Summary: HG-7-86-01 is a type II tyrosine kinase inhibitor.
- BA9022 Lck-IN-1Summary: A potent lymphocyte protein tyrosine kinase inhibitor.
- BA9054 AG-13958Summary: AG-13958 (AG-013958) is a potent tyrosine kinase inhibitor.